Drug class
Botulism Immune Globulin, Human
Botulism Immune Globulin, Human is a specific passive immunizing agent and antitoxin rather than a broad, multi-agent pharmacological class. Read more about Botulism Immune Globulin, Human
1 drugs in this class 1 manufacturers
Drugs in Botulism Immune Globulin, Human
Botulism Immune Globulin, Human is a specific passive immunizing agent and antitoxin rather than a broad, multi-agent pharmacological class.
Functionally classified within hyperimmune globulins, it consists of pooled human immunoglobulin G containing high titers of neutralizing antibodies against neurotoxins produced by *Clostridium botulinum*.
Its primary mechanism of action involves binding to free, circulating botulinum neurotoxins—principally types A and B—preventing them from attaching to presynaptic nerve endings and halting progressive neuromuscular blockade.
Clinically, its established therapeutic role is the management of infant botulism in pediatric patients less than one year of age.
-
nih.gov
Botulism Immune Globulin, Human is a specific passive immunizing agent and antitoxin rather than a broad, multi-agent pharmacological class
-
fda.gov
Botulism Immune Globulin, Human is a specific passive immunizing agent and antitoxin rather than a broad, multi-agent pharmacological class
-
nih.gov
Functionally classified within hyperimmune globulins, it consists of pooled human immunoglobulin G containing high titers of neutralizing antibodies against neurotoxins produced by *Clostridium botulinum* Its primary mechanism of action involves binding to free, circulating botulinum neurotoxins—principally types A and B—preventing them from attaching to presynaptic nerve endings and halting progressive neuromuscular blockade Clinically, its established therapeutic role is the management of infa...
-
nih.gov
Functionally classified within hyperimmune globulins, it consists of pooled human immunoglobulin G containing high titers of neutralizing antibodies against neurotoxins produced by *Clostridium botulinum* Its primary mechanism of action involves binding to free, circulating botulinum neurotoxins—principally types A and B—preventing them from attaching to presynaptic nerve endings and halting progressive neuromuscular blockade
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.